Mood stabilizers represent a class of drugs that are efficacious in the treatment of bipolar disorder. The most established medications in this class are lithium, valproic acid, and carbamazepine. In addition to their therapeutic effects for treatment of acute manic episodes, these medications often are useful as prophylaxis against future episodes and as adjunctive antidepressant medications. While important extracellular effects have not been excluded, most available evidence suggests that the therapeutically relevant targets of this class of medications are in the interior of cells. Herein we give a prospective of a rapidly evolving field, discussing common effects of mood stabilizers as well as effects that are unique to individual medications. Mood stabilizers have been shown to modulate the activity of enzymes, ion channels, arachidonic acid turnover, G protein coupled receptors and intracellular pathways involved in synaptic plasticity and neuroprotection. Understanding the therapeutic targets of mood stabilizers will undoubtedly lead to a better understanding of the pathophysiology of bipolar disorder and to the development of improved therapeutics for the treatment of this disease. Furthermore, the involvement of mood stabilizers in pathways operative in neuroprotection suggests that they may have utility in the treatment of classical neurodegenerative disorders. q
Introduction
Mood stabilizers represent a class of drugs that have been found to be efficacious in the treatment of bipolar disorder. In addition to their effectiveness in treating acute mania, many of these medications appear to be useful for prophylaxis against future manic episodes and as adjunctive antidepressants [1] . The most established medications in this class are lithium, valproic acid (valproate, VPA), and carbamazepine.
Research on the action of these drugs originally concentrated on possible receptor mediated effects; however it has become clear that they likely do not exert their actions by interacting specifically with cell surface receptors [2, 3] . The lack of interaction with cell surface receptors has prompted researchers to focus efforts on intracellular targets. This focus has led to numerous findings, including a few direct targets, for lithium, carbamazepine, and VPA [3] [4] [5] . However, it remains unclear which are the primary initial targets, and what the most therapeutically relevant downstream effects of these medications are [6] .
It is very apparent, and also confounding, that the structures of the various mood stabilizers are vastly different: lithium is a monovalent cation; VPA an eight-carbon branched chain fatty acid; and carbamazepine is structurally related to the tricyclic antidepressants (Table 1) . This observation suggests that the initial mechanism of action -or target -of mood stabilizers may not be maintained among these structurally different medications. However, because of their shared efficacy in treating bipolar disorder, it is likely that the intracellular and/or physiological effects may show convergence [7] . For this reason multiple laboratories are using biochemical and cellular methods to identify common targets of mood stabilizers [8] [9] [10] [11] [12] [13] [14] [15] .
The intent of this review is to describe research in this dynamic field, and to present the leading hypotheses regarding the mechanisms of action of mood stabilizers. Although it is not known for certain how any mood stabilizer exerts its therapeutic effects, there is suggestive evidence for various mechanisms. It appears likely that lithium exerts its initial effects by targeting the activity of an enzyme, or perhaps multiple enzymes, inside cells. Lithium has a hydrated ionic radius which is very similar to that of magnesium, and it inhibits some enzymes through competition for this required cofactor [16, 17, 248] . While lithium inhibits a number of enzymes [18] , only a few are significantly inhibited at therapeutic concentrations (0.6-1.2 mM). These include a group of at least four related phosphomonoesterases [19] , the metabolic 
